High Drug Prices, Low Productivity, Resistance To Change: Pharma’s Dysfunctional Business Model

Pharma must change, but policies, like Trump’s most favored nation rule, that ignore root causes risk irreparable harm to industry and patients.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive